Prachya Maneeprasopchoke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Prachya Maneeprasopchoke has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Amr H. Abdelhamid Ahmed
Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery, Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts USA
5 shared publications - Marika D. Russell
Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery, Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts USA
5 shared publications - Gregory William Randolph
Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery, Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts USA
4 shared publications - Paveena Pithuksurachai
Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
4 shared publications Cheerasook Chongkolwatana
Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
3 shared publications- Dipti Kamani
Division of Thyroid and Parathyroid Endocrine Surgery, Department of Otolaryngology‐Head and Neck Surgery, Massachusetts Eye and Ear Harvard Medical School Boston Massachusetts USA
3 shared publications
Latest Publications
- 11 October 2026
- Published by Wiley in Head & Neck
Probe‐Based Near‐Infrared Autofluorescence for Parathyroid Identification During Thyroid Surgery: Clinical Outcomes, Surgeon Confidence, and Autofluorescence Thresholds
Background: We evaluated experience with probe‐based near‐infrared autofluorescence (NIRAF) system (PTeye) in parathyroid gland (PTG) identification during total thyroidectomy. Methods: In this retrospective study, patients undergoing total thyroidectomy using PTeye (2020–2022; n = 84) were compared with a historical visual‐identification cohort (2018–2019; n = 103). Results: PTG identification rates were comparable, although 42% of PTGs detected with PTeye were initially visualized with low or moderate confidence. Significantly fewer patients in the PTeye cohort had PTGs incidentally identified on histology (4.8% vs. 16.5%, p = 0.018), but there was no difference in the incidence of autotransplanted PTGs or total inadvertent parathyroidectomy. Postoperative calcium was higher with PTeye (median 9.2 vs. 9.0 mg/dL, p < 0.001). Postoperative PTH, transient, and permanent hypoparathyroidism did not differ. An autofluorescence ratio cutoff of 2.5 improved specificity compared with the manufacturer‐recommended cutoff of 1.2. Conclusions: PTeye provides adjunctive confirmation of suspected parathyroid tissue, including glands initially identified with low or moderate visual confidence.
- 11 October 2026
- Published by Wiley in Head & Neck
Probe‐Based Near‐Infrared Autofluorescence for Parathyroid Identification During Thyroid Surgery: Clinical Outcomes, Surgeon Confidence, and Autofluorescence Thresholds
Background: We evaluated experience with probe‐based near‐infrared autofluorescence (NIRAF) system (PTeye) in parathyroid gland (PTG) identification during total thyroidectomy. Methods: In this retrospective study, patients undergoing total thyroidectomy using PTeye (2020–2022; n = 84) were compared with a historical visual‐identification cohort (2018–2019; n = 103). Results: PTG identification rates were comparable, although 42% of PTGs detected with PTeye were initially visualized with low or moderate confidence. Significantly fewer patients in the PTeye cohort had PTGs incidentally identified on histology (4.8% vs. 16.5%, p = 0.018), but there was no difference in the incidence of autotransplanted PTGs or total inadvertent parathyroidectomy. Postoperative calcium was higher with PTeye (median 9.2 vs. 9.0 mg/dL, p < 0.001). Postoperative PTH, transient, and permanent hypoparathyroidism did not differ. An autofluorescence ratio cutoff of 2.5 improved specificity compared with the manufacturer‐recommended cutoff of 1.2. Conclusions: PTeye provides adjunctive confirmation of suspected parathyroid tissue, including glands initially identified with low or moderate visual confidence.
- Open Access
- 28 May 2026
- Published by Elsevier in Pain Management Nursing
- Vol. 27 (5) , e1035-e1041
Pain Outcomes and Predictors in Transoral Vestibular Thyroidectomy
- 28 May 2026
- Published by Elsevier in Pain Management Nursing
- Vol. 27 (5) , e1035-e1041
Open AccessPain Outcomes and Predictors in Transoral Vestibular Thyroidectomy
- Open Access
- 6 May 2026
- Published by Elsevier in Asian Journal of Surgery
Determinants of patient preference for TOETVA versus open thyroidectomy: Patient-reported outcome measures
- 6 May 2026
- Published by Elsevier in Asian Journal of Surgery
Open AccessDeterminants of patient preference for TOETVA versus open thyroidectomy: Patient-reported outcome measures
- 23 April 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (8) , 3648-3650
A Simple Technique for Probe‐Based NIRAF ‐Guided Parathyroid Identification in TOETVA
We describe a technique for probe-based near-infrared autofluorescence (NIRAF)-guided parathyroid identification during TOETVA. The probe is mounted on a suction cannula and introduced via the central port, allowing real-time confirmation of parathyroid tissue without device modification. This approach enables integration of NIRAF into remote-access thyroid surgery.
- 23 April 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (8) , 3648-3650
A Simple Technique for Probe‐Based NIRAF ‐Guided Parathyroid Identification in TOETVA
We describe a technique for probe-based near-infrared autofluorescence (NIRAF)-guided parathyroid identification during TOETVA. The probe is mounted on a suction cannula and introduced via the central port, allowing real-time confirmation of parathyroid tissue without device modification. This approach enables integration of NIRAF into remote-access thyroid surgery.
- 5 January 2026
- Published by Wiley in Head & Neck
- Vol. 48 (6) , 1473-1482
A Novel Connector for Intraoperative Nerve Monitoring Probes in Endoscopic Thyroidectomy: Comparative Efficacy and Preclinical Evaluation in a Porcine Model
Background: This study aimed to develop a connector that adapts standard endoscopic instruments into functional nerve stimulator probes. Methods: The connector underwent engineering validation in a laboratory and preclinical testing using a porcine model. A handheld standard stimulator probe served as the control. The experimental group consisted of a long monopolar probe and two connector‐adapted probes. Recurrent laryngeal nerve (RLN) and vagus nerves were stimulated to compare the efficacy and safety of the adapted probes with the standard probe. Results: The connector, when coupled to endoscopic instruments, did not show a statistically significant difference in electromyographic (EMG) amplitude at 1 mA stimulation compared with the standard probe. Safety analysis showed no significant hemodynamic effects. Conclusion: This proof‐of‐concept study demonstrates that the developed connector, when paired with endoscopic instruments, enables reliable nerve identification and preservation during endoscopic thyroid surgery, with favorable efficacy and safety profiles.
- 5 January 2026
- Published by Wiley in Head & Neck
- Vol. 48 (6) , 1473-1482
A Novel Connector for Intraoperative Nerve Monitoring Probes in Endoscopic Thyroidectomy: Comparative Efficacy and Preclinical Evaluation in a Porcine Model
Background: This study aimed to develop a connector that adapts standard endoscopic instruments into functional nerve stimulator probes. Methods: The connector underwent engineering validation in a laboratory and preclinical testing using a porcine model. A handheld standard stimulator probe served as the control. The experimental group consisted of a long monopolar probe and two connector‐adapted probes. Recurrent laryngeal nerve (RLN) and vagus nerves were stimulated to compare the efficacy and safety of the adapted probes with the standard probe. Results: The connector, when coupled to endoscopic instruments, did not show a statistically significant difference in electromyographic (EMG) amplitude at 1 mA stimulation compared with the standard probe. Safety analysis showed no significant hemodynamic effects. Conclusion: This proof‐of‐concept study demonstrates that the developed connector, when paired with endoscopic instruments, enables reliable nerve identification and preservation during endoscopic thyroid surgery, with favorable efficacy and safety profiles.
- 14 December 2025
- Published by Wiley in Head & Neck
- Vol. 48 (5) , 1303-1310
Health‐Related Quality of Life in Patients Undergoing Surgery for Primary Hyperparathyroidism: Patient Reported Outcome Measures
Background: Parathyroidectomy is typically curative for primary hyperparathyroidism (PHPT) and may lead to health‐related quality of life (HRQL) improvements. We aim to evaluate general and disease‐specific HRQL changes in patients undergoing surgery for PHPT from their perspective. Methods: Patients completed three patient‐reported outcome measure (PROM) surveys before and after surgery: (1) Worry survey; (2) Voice Handicap Index‐10 (VHI‐10); and (3) Patient‐Reported Outcome Measurement Information System Global‐10 (PROMIS). Results: Forty‐four patients were included with a median age of 65 years, with 39 females (89%) included. Thirty‐two patients (73%) had a single adenoma, and 12 (27%) had multigland disease (parathyroid hyperplasia). Worry scores related to parathyroid cancer, parathyroid surgery, and parathyroid‐related problems significantly improved post‐operatively ( p < 0.05). On PROMIS assessment, there were improved scores in the physical health domain, mental health domain, and general health following parathyroid surgery for PHPT ( p < 0.05). Conclusion: Patients with PHPT demonstrated significant improvements in HRQL following surgery.
- 14 December 2025
- Published by Wiley in Head & Neck
- Vol. 48 (5) , 1303-1310
Health‐Related Quality of Life in Patients Undergoing Surgery for Primary Hyperparathyroidism: Patient Reported Outcome Measures
Background: Parathyroidectomy is typically curative for primary hyperparathyroidism (PHPT) and may lead to health‐related quality of life (HRQL) improvements. We aim to evaluate general and disease‐specific HRQL changes in patients undergoing surgery for PHPT from their perspective. Methods: Patients completed three patient‐reported outcome measure (PROM) surveys before and after surgery: (1) Worry survey; (2) Voice Handicap Index‐10 (VHI‐10); and (3) Patient‐Reported Outcome Measurement Information System Global‐10 (PROMIS). Results: Forty‐four patients were included with a median age of 65 years, with 39 females (89%) included. Thirty‐two patients (73%) had a single adenoma, and 12 (27%) had multigland disease (parathyroid hyperplasia). Worry scores related to parathyroid cancer, parathyroid surgery, and parathyroid‐related problems significantly improved post‐operatively ( p < 0.05). On PROMIS assessment, there were improved scores in the physical health domain, mental health domain, and general health following parathyroid surgery for PHPT ( p < 0.05). Conclusion: Patients with PHPT demonstrated significant improvements in HRQL following surgery.
- 3 November 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (1) , 505-513
A Randomized Controlled Trial of Intraoperative Nerve Monitoring in Resident‐Performed Thyroidectomy
Objective: Intraoperative nerve monitoring (IONM) is widely used in thyroidectomy to aid recurrent laryngeal nerve (RLN) identification and preservation. This study assessed whether IONM improves RLN identification time and overall operative time in less experienced otorhinolaryngology residents performing thyroidectomies. Methods: This randomized controlled trial was conducted at Siriraj Hospital, Bangkok, from January 2020 to February 2021. A total of 80 patients were randomly assigned to an IONM or non‐IONM group. A total of 10 residents performed eight thyroidectomies each, using IONM in four procedures and non‐IONM methods in the other four. Results: RLN identification was significantly quicker in the IONM group (6.7 vs. 19.7 min for primary identification, 11.0 vs. 19.7 min for visual identification). IONM increased setup and nerve dissection time but without significant differences in overall operative time or RLN injury rates. Conclusions: IONM improves RLN identification efficiency in surgical training but does not significantly impact overall operative time or RLN injury rates. Level of Evidence: 2. Trial Registration: Clinical Trials Registry (TCTR20191224001).
- 3 November 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (1) , 505-513
A Randomized Controlled Trial of Intraoperative Nerve Monitoring in Resident‐Performed Thyroidectomy
Objective: Intraoperative nerve monitoring (IONM) is widely used in thyroidectomy to aid recurrent laryngeal nerve (RLN) identification and preservation. This study assessed whether IONM improves RLN identification time and overall operative time in less experienced otorhinolaryngology residents performing thyroidectomies. Methods: This randomized controlled trial was conducted at Siriraj Hospital, Bangkok, from January 2020 to February 2021. A total of 80 patients were randomly assigned to an IONM or non‐IONM group. A total of 10 residents performed eight thyroidectomies each, using IONM in four procedures and non‐IONM methods in the other four. Results: RLN identification was significantly quicker in the IONM group (6.7 vs. 19.7 min for primary identification, 11.0 vs. 19.7 min for visual identification). IONM increased setup and nerve dissection time but without significant differences in overall operative time or RLN injury rates. Conclusions: IONM improves RLN identification efficiency in surgical training but does not significantly impact overall operative time or RLN injury rates. Level of Evidence: 2. Trial Registration: Clinical Trials Registry (TCTR20191224001).
- Open Access
- 26 February 2021
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 6 (2) , 354-361
Intraoperative nerve monitoring in thyroid surgery: Analysis of recurrent laryngeal nerve identification and operative time
Objective: To evaluate the clinical value of intraoperative nerve monitoring (IONM) by comparing the procedure times for thyroidectomies performed with and without IONM.Methods: A prospective, randomized, controlled study was conducted on 32 patients (representing 41 nerves at risk) undergoing thyroidectomies carried out by two experienced head and neck surgeons (CC & WP). Sixteen thyroidectomies were performed without IONM (the “non‐IONM group”), while 16 thyroidectomies were performed with IONM (the “IONM group”). The measured datapoints were setup time, time to visual identification of the recurrent laryngeal nerve (RLN), time to confirm the RLN electrophysiologically, dissection time, and total operative time.Results: With both surgeons, the IONM group had shorter visual times to RLN identification than the non‐IONM group (CC: 3.7 minutes vs 5.3 minutes; WP: 3.4 minutes vs 9.7 minutes). Additionally, the electrophysiological identification time for the IONM group was shorter than the visual identification time for the non‐IONM group. The setup times, dissection times, and total operative times of the 2 groups did not significantly differ (P > .05). No RLN injuries were observed.Conclusions: IONM reduces the time needed for RLN identification in thyroidectomies. Functional RLN confirmation can reassure surgeons of the operative results. Moreover, use of IONM does not significantly impact setup and total operative times.Level of evidence: 2.
- 26 February 2021
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 6 (2) , 354-361
Open AccessIntraoperative nerve monitoring in thyroid surgery: Analysis of recurrent laryngeal nerve identification and operative time
Objective: To evaluate the clinical value of intraoperative nerve monitoring (IONM) by comparing the procedure times for thyroidectomies performed with and without IONM.Methods: A prospective, randomized, controlled study was conducted on 32 patients (representing 41 nerves at risk) undergoing thyroidectomies carried out by two experienced head and neck surgeons (CC & WP). Sixteen thyroidectomies were performed without IONM (the “non‐IONM group”), while 16 thyroidectomies were performed with IONM (the “IONM group”). The measured datapoints were setup time, time to visual identification of the recurrent laryngeal nerve (RLN), time to confirm the RLN electrophysiologically, dissection time, and total operative time.Results: With both surgeons, the IONM group had shorter visual times to RLN identification than the non‐IONM group (CC: 3.7 minutes vs 5.3 minutes; WP: 3.4 minutes vs 9.7 minutes). Additionally, the electrophysiological identification time for the IONM group was shorter than the visual identification time for the non‐IONM group. The setup times, dissection times, and total operative times of the 2 groups did not significantly differ (P > .05). No RLN injuries were observed.Conclusions: IONM reduces the time needed for RLN identification in thyroidectomies. Functional RLN confirmation can reassure surgeons of the operative results. Moreover, use of IONM does not significantly impact setup and total operative times.Level of evidence: 2.
- Open Access
- 1 September 2020
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 16
Giant accessory submandibular sialolithiasis: A case report
- 1 September 2020
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 16
Open AccessGiant accessory submandibular sialolithiasis: A case report
- Open Access
- 1 February 2019
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 1465-1473
BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
Purpose: Fine-needle aspiration biopsy (FNAB) is regarded by the Bethesda system as the gold-standard investigation for stratifying the risk of malignancy of a thyroid nodule. However, some limitations affect the adequacy of the obtained materials, resulting in 30% of the cytological results remaining in the indeterminate category. We aimed to investigate the diagnostic value of the BRAF mutation in cytologically indeterminate thyroid nodules after the reclassification of a variant thyroid carcinoma. Patients and methods: In this prospective diagnostic study, 76 patients with FNAB findings of atypia of undetermined significance (AUS) and suspicious for malignancy (SUS) were included. The BRAF V600 mutation from FNAB was confirmed by a PCR-based method (Sanger sequencing combined with allele-specific real-time PCR techniques) and immunohistochemistry (IHC). Pathological specimens and features, including noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), were reviewed and compared to the FNAB results. Results: Using the PCR-based method, the BRAF mutation was positive in 13/76 cases (17.1%), with the diagnostic values of 16.7% sensitivity, 100% specificity, 100% positive predictive value (PPV), and 82.8% negative predictive value (NPV) in the AUS compared to 73.3% sensitivity, 100% specificity, 100% PPV, and 20% NPV in the SUS. For the IHC technique, only 20 of the 76 cytological specimens were qualified for testing. The BRAF mutation was positive in 13/20 cases, with the diagnostic values of 100% sensitivity, 63.6% specificity, 42.9% PPV, and 100% NPV in the AUS compared to 100% sensitivity and PPV in the SUS. The BRAF mutation was not found in the pathological reports for NIFTP. Conclusion: The malignancy rate is high in our data, with specific and acceptable accuracy rates for the BRAF mutation from FNAB found by using the PCR-based method. NIFTP has been introduced after the pathological reclassification. Molecular diagnosis might be useful to establish the nature of the disease.
- 1 February 2019
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 1465-1473
Open AccessBRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
Purpose: Fine-needle aspiration biopsy (FNAB) is regarded by the Bethesda system as the gold-standard investigation for stratifying the risk of malignancy of a thyroid nodule. However, some limitations affect the adequacy of the obtained materials, resulting in 30% of the cytological results remaining in the indeterminate category. We aimed to investigate the diagnostic value of the BRAF mutation in cytologically indeterminate thyroid nodules after the reclassification of a variant thyroid carcinoma. Patients and methods: In this prospective diagnostic study, 76 patients with FNAB findings of atypia of undetermined significance (AUS) and suspicious for malignancy (SUS) were included. The BRAF V600 mutation from FNAB was confirmed by a PCR-based method (Sanger sequencing combined with allele-specific real-time PCR techniques) and immunohistochemistry (IHC). Pathological specimens and features, including noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), were reviewed and compared to the FNAB results. Results: Using the PCR-based method, the BRAF mutation was positive in 13/76 cases (17.1%), with the diagnostic values of 16.7% sensitivity, 100% specificity, 100% positive predictive value (PPV), and 82.8% negative predictive value (NPV) in the AUS compared to 73.3% sensitivity, 100% specificity, 100% PPV, and 20% NPV in the SUS. For the IHC technique, only 20 of the 76 cytological specimens were qualified for testing. The BRAF mutation was positive in 13/20 cases, with the diagnostic values of 100% sensitivity, 63.6% specificity, 42.9% PPV, and 100% NPV in the AUS compared to 100% sensitivity and PPV in the SUS. The BRAF mutation was not found in the pathological reports for NIFTP. Conclusion: The malignancy rate is high in our data, with specific and acceptable accuracy rates for the BRAF mutation from FNAB found by using the PCR-based method. NIFTP has been introduced after the pathological reclassification. Molecular diagnosis might be useful to establish the nature of the disease.